MA41818A - Timbre à micro-aiguilles pour administration d'un principe actif à la peau - Google Patents
Timbre à micro-aiguilles pour administration d'un principe actif à la peauInfo
- Publication number
- MA41818A MA41818A MA041818A MA41818A MA41818A MA 41818 A MA41818 A MA 41818A MA 041818 A MA041818 A MA 041818A MA 41818 A MA41818 A MA 41818A MA 41818 A MA41818 A MA 41818A
- Authority
- MA
- Morocco
- Prior art keywords
- administration
- skin
- micro
- active substance
- needle stamp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0061—Methods for using microneedles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15161262 | 2015-03-27 | ||
EP15176101 | 2015-07-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA41818A true MA41818A (fr) | 2018-01-30 |
Family
ID=55910913
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA041818A MA41818A (fr) | 2015-03-27 | 2016-03-15 | Timbre à micro-aiguilles pour administration d'un principe actif à la peau |
Country Status (20)
Country | Link |
---|---|
US (2) | US20180078498A1 (fr) |
EP (1) | EP3273942B1 (fr) |
JP (1) | JP6929784B2 (fr) |
KR (1) | KR20170131642A (fr) |
CN (1) | CN107405301B (fr) |
AU (1) | AU2016239277B2 (fr) |
BR (1) | BR112017020511A2 (fr) |
CA (1) | CA2979435A1 (fr) |
DK (1) | DK3273942T3 (fr) |
ES (1) | ES2886129T3 (fr) |
HK (1) | HK1246208A1 (fr) |
IL (1) | IL254183A0 (fr) |
MA (1) | MA41818A (fr) |
MX (1) | MX2017012321A (fr) |
MY (1) | MY191513A (fr) |
PL (1) | PL3273942T3 (fr) |
SG (1) | SG11201707141TA (fr) |
UA (1) | UA124141C2 (fr) |
WO (1) | WO2016155891A1 (fr) |
ZA (2) | ZA201706259B (fr) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170348218A1 (en) * | 2016-06-03 | 2017-12-07 | Sanova Bioscience Inc | Microneedle patch containing hyaluronic acid for cosmetic use |
WO2018151832A1 (fr) * | 2017-02-17 | 2018-08-23 | Allergan, Inc. | Réseau de micro-aiguilles avec principe actif |
EP3694487A1 (fr) | 2017-10-11 | 2020-08-19 | Georgia Tech Research Corporation | Matrices de microaiguilles séparables pour libération prolongée de médicament |
SG10201800072YA (en) * | 2018-01-03 | 2019-08-27 | Micropoint Tech Pte Ltd | Microneedle Patches Comprising Corticosteroid |
KR102094744B1 (ko) * | 2018-01-26 | 2020-03-30 | 가천대학교 산학협력단 | 마이크로 니들 및 이의 제조방법 |
WO2019168926A1 (fr) * | 2018-02-28 | 2019-09-06 | BandGrip, Inc. | Ensemble de fermeture de plaie sous-cutanée et procédé d'utilisation |
EP3765029A4 (fr) * | 2018-04-13 | 2021-12-08 | North Carolina State University | Timbre à micro-aiguilles sensible aux ero pour le traitement de l'acné vulgaire |
KR102146704B1 (ko) * | 2018-04-13 | 2020-08-21 | 가천대학교 산학협력단 | 사이클로스포린 A (CsA) 경피 및 피내 약물전달용 마이크로구조체 |
US20210244681A1 (en) * | 2018-05-18 | 2021-08-12 | Postech Academy-Industry Foundation | Transtermal drug delivery patch and manufacturing method thereof |
JP2021522978A (ja) * | 2018-05-18 | 2021-09-02 | ポステック アカデミー−インダストリー ファンデーション | 経皮透過型薬物伝達パッチおよびその製造方法 |
CN108721204A (zh) * | 2018-06-04 | 2018-11-02 | 南京紫源康医药科技有限公司 | 一种可溶性紫草素微针贴片及其制备方法 |
CN108703895B (zh) * | 2018-08-21 | 2021-02-09 | 广州香蒲兰电子商务有限公司 | 一种深层渗透的长效保湿凝胶及制备方法 |
CN110870846A (zh) * | 2018-08-31 | 2020-03-10 | 中科微针(北京)科技有限公司 | 一种可快速植入型缓释微针贴片及其制备方法 |
CN110917176B (zh) * | 2018-08-31 | 2021-03-30 | 中科微针(北京)科技有限公司 | 一种可植入型缓释微针贴片及其制备方法 |
CN108888577B (zh) * | 2018-09-11 | 2021-09-14 | 无锡元旭生物技术有限公司 | 一种可溶性玻尿酸美容微针贴及其制备方法 |
WO2020064083A1 (fr) * | 2018-09-24 | 2020-04-02 | L'oreal | Dispositif comprenant des micro-aiguilles pour la réaction in situ d'une peau |
JP2020099513A (ja) * | 2018-12-21 | 2020-07-02 | ロレアル | マイクロニードルシートを使用するキット及び美容方法 |
GB201908229D0 (en) | 2019-06-10 | 2019-07-24 | Univ College Cork National Univ Of Ireland | Microneedles and methods for the manufacture thereof |
JP2022539837A (ja) * | 2019-07-10 | 2022-09-13 | マイニード テクノロジー カンパニー リミテッド | 溶解性マイクロニードル |
JP2022553337A (ja) * | 2019-10-22 | 2022-12-22 | ジョージア テック リサーチ コーポレイション | 流延配合物中の成分溶解度の調整を使用してマイクロニードルを作製するための方法 |
US20230073125A1 (en) * | 2019-10-29 | 2023-03-09 | The Regents Of The University Of California | Periodontal micropatch and uses thereof |
EP4061334A4 (fr) | 2019-11-22 | 2024-02-14 | Veradermics Incorporated | Patch à micro-aiguilles pour l'administration de médicaments immunostimulateurs |
US20230015942A1 (en) * | 2019-12-11 | 2023-01-19 | The Regents Of The University Of California | Microneedle delivery device with detachable hybrid microneedle depots for localized delivery of cells |
NL2026264B1 (en) | 2020-08-13 | 2022-04-13 | Versailles B V | Microneedle applicator with active ingredient for treatment of skin lesions |
HUP2000309A1 (hu) | 2020-09-18 | 2022-04-28 | Semmelweis Egyetem | Bõrtapasz a SARS-CoV-2 vírusfertõzöttség elleni immunvédettség celluláris diagnosztikai vizsgálatához |
CN112294750B (zh) * | 2020-10-29 | 2023-06-20 | 广东药科大学 | 一种吲哚美辛胶束复合微针及其制备方法 |
CN112516449B (zh) * | 2020-12-03 | 2023-02-21 | 昆明理工大学 | 一种可溶性微针阵列及其制备方法 |
IL307205A (en) * | 2021-03-23 | 2023-11-01 | Veradermics Incorporated | Peri-lesional treatment of skin conditions |
CN115581659A (zh) * | 2021-07-05 | 2023-01-10 | 刘野 | 一种非甾体类抗炎药微针及其制备方法 |
WO2023014375A1 (fr) * | 2021-08-06 | 2023-02-09 | Lean Life Sciences, Inc | Peptides cosmétiques pour améliorer le rajeunissement de la peau |
KR20230129639A (ko) * | 2022-03-02 | 2023-09-11 | 연세대학교 산학협력단 | 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태 |
WO2023194999A1 (fr) * | 2022-04-07 | 2023-10-12 | Sheba Impact Ltd. | Micro-aiguilles biodégradables flexibles |
WO2023218230A1 (fr) * | 2022-05-13 | 2023-11-16 | Mineed Technology Company Limited | Timbre à micro-aiguilles solubles |
CN115317439A (zh) * | 2022-07-18 | 2022-11-11 | 合肥博思科创医药科技有限公司 | 一种克立硼罗微针贴剂及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE39706E1 (en) | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
HU230045B1 (hu) * | 1999-04-23 | 2015-06-29 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) | Bőrgyógyászati alkalmazásra szolgáló nem vizes gyógyszerkészítmény |
PL360998A1 (en) | 2000-10-13 | 2004-09-20 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
WO2002064193A2 (fr) | 2000-12-14 | 2002-08-22 | Georgia Tech Research Corporation | Appareils a microaiguilles et fabrication |
US6893431B2 (en) * | 2001-10-15 | 2005-05-17 | Scimed Life Systems, Inc. | Medical device for delivering patches |
EP1827564B1 (fr) * | 2004-11-18 | 2015-07-29 | 3M Innovative Properties Company | Procede de masquage pour le revetement d'un jeu de micro-aiguilles |
US7651946B2 (en) | 2005-12-12 | 2010-01-26 | University College Cork - National University Of Ireland, Cork | Wet etch processing |
CN1857730B (zh) * | 2006-03-30 | 2010-05-12 | 西安交通大学 | 带微孔的多腔体可降解植入式药物控释载体及其制备工艺 |
US20090182306A1 (en) * | 2006-07-21 | 2009-07-16 | Georgia Tech Research Corporation | Microneedle Devices and Methods of Drug Delivery or Fluid Withdrawal |
EP2121111B1 (fr) | 2007-01-22 | 2018-03-14 | Corium International, Inc. | Applicateurs pour micro-aiguilles |
US20100233194A1 (en) * | 2007-03-30 | 2010-09-16 | Jean-Philippe Combal | Treatment of neovascular ocular disease states |
WO2008130587A2 (fr) | 2007-04-16 | 2008-10-30 | Corium International, Inc. | Réseaux de micro-aiguilles coulées dans un solvant contenant un actif |
AU2014200648B2 (en) * | 2007-04-16 | 2015-09-24 | Corium Pharma Solutions, Inc. | Solvent-cast microneedle arrays containing active |
KR101634836B1 (ko) * | 2008-12-26 | 2016-06-29 | 히사미쓰 세이야꾸 가부시키가이샤 | 마이크로 니들 디바이스 |
US9687641B2 (en) * | 2010-05-04 | 2017-06-27 | Corium International, Inc. | Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
GB201019577D0 (en) * | 2010-11-18 | 2010-12-29 | Univ Cork | Method |
GB201107642D0 (en) | 2011-05-09 | 2011-06-22 | Univ Cork | Method |
CN104027324B (zh) * | 2013-03-06 | 2017-12-15 | 中国科学院理化技术研究所 | 一种可溶性微针疫苗贴片及其制备方法 |
BR112015022625B1 (pt) * | 2013-03-15 | 2023-01-31 | Corium, Inc | Aparelho de microestrutura para entrega de agente terapêutico |
JP6370296B2 (ja) * | 2013-07-30 | 2018-08-08 | Asti株式会社 | マイクロニードルアレイとマイクロニードルアレイ製造方法 |
US20150057505A1 (en) * | 2013-08-22 | 2015-02-26 | Elwha Llc | Method for Administering a Medicament to a Fetus |
-
2016
- 2016-03-15 MA MA041818A patent/MA41818A/fr unknown
- 2016-03-16 PL PL16720351T patent/PL3273942T3/pl unknown
- 2016-03-16 CA CA2979435A patent/CA2979435A1/fr not_active Abandoned
- 2016-03-16 US US15/562,278 patent/US20180078498A1/en not_active Abandoned
- 2016-03-16 KR KR1020177031075A patent/KR20170131642A/ko unknown
- 2016-03-16 SG SG11201707141TA patent/SG11201707141TA/en unknown
- 2016-03-16 DK DK16720351.2T patent/DK3273942T3/da active
- 2016-03-16 MY MYPI2017703556A patent/MY191513A/en unknown
- 2016-03-16 CN CN201680018427.1A patent/CN107405301B/zh active Active
- 2016-03-16 EP EP16720351.2A patent/EP3273942B1/fr active Active
- 2016-03-16 MX MX2017012321A patent/MX2017012321A/es unknown
- 2016-03-16 ES ES16720351T patent/ES2886129T3/es active Active
- 2016-03-16 BR BR112017020511A patent/BR112017020511A2/pt not_active Application Discontinuation
- 2016-03-16 UA UAA201710326A patent/UA124141C2/uk unknown
- 2016-03-16 WO PCT/EP2016/025026 patent/WO2016155891A1/fr active Application Filing
- 2016-03-16 JP JP2017550507A patent/JP6929784B2/ja active Active
- 2016-03-16 AU AU2016239277A patent/AU2016239277B2/en not_active Ceased
-
2017
- 2017-08-28 IL IL254183A patent/IL254183A0/en unknown
- 2017-09-14 ZA ZA2017/06259A patent/ZA201706259B/en unknown
-
2018
- 2018-05-08 HK HK18105946.4A patent/HK1246208A1/zh unknown
- 2018-09-13 ZA ZA2018/06163A patent/ZA201806163B/en unknown
-
2023
- 2023-01-13 US US18/154,566 patent/US20230404909A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SG11201707141TA (en) | 2017-10-30 |
KR20170131642A (ko) | 2017-11-29 |
CN107405301B (zh) | 2021-11-30 |
WO2016155891A1 (fr) | 2016-10-06 |
US20180078498A1 (en) | 2018-03-22 |
MY191513A (en) | 2022-06-28 |
BR112017020511A2 (pt) | 2018-07-10 |
ZA201706259B (en) | 2018-12-19 |
CA2979435A1 (fr) | 2016-10-06 |
IL254183A0 (en) | 2017-10-31 |
MX2017012321A (es) | 2018-01-18 |
UA124141C2 (uk) | 2021-07-28 |
AU2016239277A1 (en) | 2017-09-28 |
EP3273942A1 (fr) | 2018-01-31 |
US20230404909A1 (en) | 2023-12-21 |
HK1246208A1 (zh) | 2018-09-07 |
ZA201806163B (en) | 2019-12-18 |
JP2018510170A (ja) | 2018-04-12 |
PL3273942T3 (pl) | 2021-12-06 |
DK3273942T3 (da) | 2021-09-13 |
RU2017134576A3 (fr) | 2019-08-27 |
EP3273942B1 (fr) | 2021-06-16 |
ES2886129T3 (es) | 2021-12-16 |
RU2017134576A (ru) | 2019-04-04 |
JP6929784B2 (ja) | 2021-09-01 |
CN107405301A (zh) | 2017-11-28 |
AU2016239277B2 (en) | 2019-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA41818A (fr) | Timbre à micro-aiguilles pour administration d'un principe actif à la peau | |
CY1124729T1 (el) | Φαρμακοτεχνικες μορφες του ενζαλουταμιδιου | |
IL264413B (en) | Preparations containing fibers obtained electrohydrodynamically for delivering specific doses of active substance to the skin or mucous membrane | |
FR3007969B1 (fr) | Distributeur d'une dose unitaire d'une substance active sous une forme galenique solide | |
IL264025A (en) | Novel fatty acid-modified urocortin-2 analogs for the treatment of diabetes and chronic kidney disease | |
MA42032A (fr) | Acides 3-aryl-4-amido-bicyclo [4,5,0]hydroxamiques en tant qu'inhibiteurs de hdac | |
UY35306A (es) | Formulaciones farmacéuticas estabilizadas de análogos de insulina y/o derivados de insulina. | |
MA49141A (fr) | Composés pyrrolopyridine-aniline destinés au traitement d'affections de la peau | |
MA49116A (fr) | Compositions pharmaceutiques contenant de l'insuline | |
MA54716A (fr) | Réduction de la viscosité de formulations pharmaceutiques | |
CL2015002346A1 (es) | Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3) | |
FR3016521B1 (fr) | Principe actif obtenu a partir de pichia anomala et utilisation pour lutter contre le phenomene d'inflammation chronique de la peau | |
MA40781A (fr) | Composition pharmaceutique d'isotrétinoïne à faible dosage destinée à la voie orale | |
CL2015002933A1 (es) | Identificación de la respuesta del paciente a la administración de un modulador del receptor s1p. | |
CL2015001881A1 (es) | Compuesto 4-hidroxi-2-metil-5-(propan-2-iliden)ciclohexil-3-en-1-carbaldehido; uso del compuesto para el tratamiento de la enfermedad de alzheimer; composición farmacéutica; método para preparar la composición. | |
CL2015003563A1 (es) | Marcador para trastornos de la esfingomielinasa ácida y sus usos. | |
FR2998174B1 (fr) | Procede de preparation d'un principe actif cosmetique ou dermatologique | |
FR3011183B1 (fr) | Utilisation d'une composition huileuse contenant un extrait d'hemerocalle pour ameliorer la fermete de la peau. | |
FR2989275B1 (fr) | Principe actif a application cutanee obtenu a partir de metschnikowia agaves et utilisations pour ameliorer l'etat de la peau | |
MA51822A (fr) | Extraction d'acides alcanoïques | |
MA50458A (fr) | Formulations topiques destinées au traitement d'affections dermatologiques comprenant la calvitie hippocratique | |
FR3025096B1 (fr) | Composition gel/gel contenant un actif anti-transpirant | |
IT201700038005A1 (it) | Dispositivo per la somministrazione di sostanze | |
ITUB20169928A1 (it) | Formulazioni farmaceutiche per il trattamento del diabete | |
FR3008891B1 (fr) | Principe actif a application cutanee obtenu a partir de metschnikowia pulcherrima et utilisation cosmetique |